These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10644281)

  • 41. FDA drug-review, surveillance processes under scrutiny.
    Miller JL
    Am J Health Syst Pharm; 1999 Mar; 56(5):404, 406, 408. PubMed ID: 10096696
    [No Abstract]   [Full Text] [Related]  

  • 42. Do thiazolidinediones cause congestive heart failure?
    Kennedy FP
    Mayo Clin Proc; 2003 Sep; 78(9):1076-7. PubMed ID: 12962160
    [No Abstract]   [Full Text] [Related]  

  • 43. [Proper usage of thiazolidinediones].
    Shimizu N
    Nihon Rinsho; 2000 Feb; 58(2):383-8. PubMed ID: 10707562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thiazolidinedione hepatotoxicity: a class effect?
    Tolman KG
    Int J Clin Pract Suppl; 2000 Oct; (113):29-34. PubMed ID: 11965828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GSK fights compensation claims from UK patients who took rosiglitazone.
    Dyer C
    BMJ; 2013 Feb; 346():f695. PubMed ID: 23377792
    [No Abstract]   [Full Text] [Related]  

  • 46. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.
    Osei SY; Koro CE; Cobitz AR; Kolatkar NS; Stender M
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1244-6. PubMed ID: 19655316
    [No Abstract]   [Full Text] [Related]  

  • 47. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al.
    Beiderbeck AB; Sakaguchi M
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1247-9. PubMed ID: 19842093
    [No Abstract]   [Full Text] [Related]  

  • 48. Late-onset troglitazone-induced hepatic dysfunction.
    Bell DS; Ovalle F
    Diabetes Care; 2000 Jan; 23(1):128-9. PubMed ID: 10857986
    [No Abstract]   [Full Text] [Related]  

  • 49. [Rosiglitazone (BRL-49653)].
    Oka Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():438-41. PubMed ID: 12387030
    [No Abstract]   [Full Text] [Related]  

  • 50. Rosiglitazone in the management of older patients with type 2 diabetes mellitus.
    Kreider M; Heise M
    Int J Clin Pract; 2002 Sep; 56(7):538-41. PubMed ID: 12296617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The critically ill liver: hepatic ischemia].
    Trujillo MH; Hernández Adrían G
    G E N; 1992; 46(1):61-7. PubMed ID: 1305120
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug recalls underscore safety concerns.
    Greene HL
    Health News; 2000 May; 6(5):4. PubMed ID: 10851966
    [No Abstract]   [Full Text] [Related]  

  • 53. Serious liver injury. Leading reason for drug removals, restrictions.
    Meadows M
    FDA Consum; 2001; 35(3):8-9. PubMed ID: 11458559
    [No Abstract]   [Full Text] [Related]  

  • 54. What caused this patient's sudden liver dysfunction?
    Porterfield LM
    RN; 2001 Mar; 64(3):98. PubMed ID: 11288655
    [No Abstract]   [Full Text] [Related]  

  • 55. Substituting for troglitazone (Rezulin).
    Med Lett Drugs Ther; 2000 Apr; 42(1076):36. PubMed ID: 10803176
    [No Abstract]   [Full Text] [Related]  

  • 56. Diabetes drug withdrawn after reports of hepatic events.
    Wise J
    BMJ; 1997 Dec; 315(7122):1564. PubMed ID: 9437272
    [No Abstract]   [Full Text] [Related]  

  • 57. Rezulin pulled in the UK.
    Zurlinden J
    Nurs Spectr (Wash D C); 1998 May; 8(9):25. PubMed ID: 10542729
    [No Abstract]   [Full Text] [Related]  

  • 58. Rezulin to be withdrawn from the market.
    Diabetes Technol Ther; 2000; 2(2):289. PubMed ID: 11469272
    [No Abstract]   [Full Text] [Related]  

  • 59. Severe but reversible cholestatic liver injury after pioglitazone therapy.
    Pinto AG; Cummings OW; Chalasani N
    Ann Intern Med; 2002 Nov; 137(10):857. PubMed ID: 12435231
    [No Abstract]   [Full Text] [Related]  

  • 60. Hepatocellular injury in a patient receiving pioglitazone.
    Maeda K
    Ann Intern Med; 2001 Aug; 135(4):306. PubMed ID: 11511159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.